Revenue
Total Revenue
Pfizer Total Revenue decreased by 17.7% to $14.45B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.4%, from $13.72B to $14.45B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows a downward trend with a -6.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionRevenue
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase indicates growing market demand or successful price increases, while a decrease suggests market saturation or competitive pressure.
Detailed definition
The total amount of income generated by the sale of goods or services related to the company's primary operations. For a...
Peer comparison
Peer technology firms typically report this as Net Sales or Total Revenue, reflecting the scale of their market reach.
Metric ID:
total_revenueHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.98B | $24.09B | $23.64B | $25.66B | $27.74B | $22.64B | $24.29B | $18.28B | $12.73B | $13.23B | $14.25B | $14.88B | $13.28B | $17.70B | $17.76B | $13.72B | $14.65B | $16.65B | $17.56B | $14.45B |
| QoQ Change | — | +27.0% | -1.9% | +8.6% | +8.1% | -18.4% | +7.3% | -24.7% | -30.3% | +3.9% | +7.7% | +4.4% | -10.7% | +33.3% | +0.3% | -22.8% | +6.8% | +13.7% | +5.4% | -17.7% |
| YoY Change | — | — | — | — | +46.2% | -6.0% | +2.8% | -28.8% | -54.1% | -41.5% | -41.3% | -18.6% | +4.3% | +33.8% | +24.7% | -7.8% | +10.3% | -5.9% | -1.2% | +5.4% |
Range$12.73B – $27.74B
CAGR-5.6%
Avg YoY Growth-4.9%
Median YoY Growth-3.5%
Product Breakdown
| Segment | Q2 '21 | Q3 '21 | Q1 '25 | Q1 '26 |
|---|---|---|---|---|
| Royalty | — | — | — | $396.00M |
| Pfizer CentreOne | $437.00M | $521.00M | $273.00M | $289.00M |
| Total | $18.98B | $24.09B | $13.72B | $14.45B |
Business Segments
| Segment | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Biopharma | $27.43B | $22.32B | $23.92B | $17.97B | $12.42B | $12.93B | $13.44B | $14.16B |
| Total | $27.74B | $22.64B | $24.29B | $18.28B | $12.73B | $13.23B | $13.72B | $14.45B |
Geographic Breakdown
| Segment | Q1 '26 |
|---|---|
| International Developed Markets | $3.43B |
| International Emerging Markets | $2.29B |
| Total | $14.45B |
Total Revenue at Other Companies
Frequently Asked Questions
- What is Pfizer's total revenue?
- Pfizer (PFE) reported total revenue of $14.45B in Q1 2026.
- How has Pfizer's total revenue changed year-over-year?
- Pfizer's total revenue increased by 5.4% year-over-year, from $13.72B to $14.45B.
- What is the long-term trend for Pfizer's total revenue?
- Over 4 years (2021 to 2025), Pfizer's total revenue has grown at a -6.3% compound annual growth rate (CAGR), from $81.29B to $62.58B.
- What does total revenue mean?
- The total amount of money a company brings in from selling its products and services.